MedDay has strengthened its board with the addition of Sanofi’s former VP of corporate licenses.
Philippe Goupit has more than 30 years’ experience in the pharma industry, including 20 years at France-based pharma giant Sanofi where he also served as head of corporate mergers and acquisitions and head of investor relations.
MedDay, which was only formed in 2011, will welcome Goupit’s knowledge of business development as it looks to expand with its pipeline of drugs for nervous system disorders such as multiple scleroris.
Goupit said: “I strongly believe that MedDay’s product pipeline and its research platform, SPECMET, could have a major impact on the treatment of neurological and psychiatric diseases.”